Gómez-Aguayo, Francisco
Paczka, José A.
Leñero-Córdova, Rubén
Jiménez-Román, Jesús
Davila-Villarreal, Jaime
Hartleben, Curt
Baiza-Durán, Leopoldo
Olvera-Montaño, Oscar
García-Velez, Francisco
Muñoz-Villegas, Patricia http://orcid.org/0000-0002-7559-1218
Clinical trials referenced in this document:
Documents that mention this clinical trial
A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination in Patients with Controlled Primary Open-Angle Glaucoma
https://doi.org/10.1007/s40123-018-0128-8
Article History
Received: 2 March 2018
First Online: 21 April 2018